Cost-effectiveness of first-line antiretroviral therapy for HIV-infected African children less than 3 years of age

BACKGROUND: The International Maternal, Pediatric, and Adolescent Clinical Trials P1060 trial demonstrated superior outcomes for HIV-infected children less than 3 years old initiating antiretroviral therapy (ART) with lopinavir/ritonavir compared to nevirapine, but lopinavir/ritonavir is four-fold c...

Descripción completa

Detalles Bibliográficos
Autores principales: Ciaranello, Andrea L., Doherty, Kathleen, Penazzato, Martina, Lindsey, Jane C., Harrison, Linda, Kelly, Kathleen, Walensky, Rochelle P., Essajee, Shaffiq, Losina, Elena, Muhe, Lulu, Wools-Kaloustian, Kara, Ayaya, Samuel, Weinstein, Milton C., Palumbo, Paul, Freedberg, Kenneth A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2015
Materias:
Epidemiology and Social
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536981/
https://www.ncbi.nlm.nih.gov/pubmed/25870982
http://dx.doi.org/10.1097/QAD.0000000000000672

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536981/
https://www.ncbi.nlm.nih.gov/pubmed/25870982
http://dx.doi.org/10.1097/QAD.0000000000000672

Ejemplares similares